150 Participants Needed

Brain Stimulation for Fibromyalgia

RH
JD
RH
AH
AD
Overseen ByAlexandre Dasilva, DDs,DMedSc
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This project is being conducted to evaluate the impact of explosive synchronization (ES) and its treatment with non-invasive brain stimulation in fibromyalgia (FM). The study design has three components, however, only 2 aims are enrolling participants. The first part (Aim1) is a cross sectional assessment of brain network explosive synchronization activity, connectivity, and response to pain in healthy controls and age and sex-matched fibromyalgia patients; the third part (Aim 3) is a longitudinal assessment of fibromyalgia patients undergoing one week of sham followed by high-definition transcranial direct current stimulation (HD-tDCS) of the motor cortex (M1) or one week of ES HD-tDCS of a brain region identified from computer modelling (Aim 2).

Will I have to stop taking my current medications?

The trial requires that you do not use stimulant medications or routine daily use of opioid analgesics. You also cannot use over-the-counter pain medications on the day of certain tests or opioid painkillers 48 hours before some scans. Other medications may be allowed, but you should not start any new treatments for fibromyalgia during the study.

What data supports the effectiveness of this treatment for fibromyalgia?

Research shows that transcranial direct current stimulation (tDCS) can reduce pain in fibromyalgia patients. Studies found that active tDCS over specific brain areas significantly decreased pain scores and improved disability compared to sham treatments.12345

Is brain stimulation for fibromyalgia safe for humans?

Transcranial direct current stimulation (tDCS), including its high-definition version (HD-tDCS), is generally considered safe and well tolerated in humans, although more research is needed, especially at higher intensities and in older adults.14678

How is HD-tDCS treatment different from other treatments for fibromyalgia?

HD-tDCS (High-Definition Transcranial Direct Current Stimulation) is unique because it uses a more focused electrical stimulation to modulate brain activity, specifically targeting the primary motor cortex, which can help reduce pain in fibromyalgia patients. Unlike traditional treatments, it is non-invasive and can provide immediate and lasting pain relief without medication.123910

Research Team

AD

Alexandre Dasilva, DDs,DMedsc

Principal Investigator

University of Michigan

Eligibility Criteria

This trial is for adults with fibromyalgia experiencing pain most days, and healthy right-handed controls with minimal pain. Participants must be able to visit the study site regularly and not start new treatments during the study. Exclusions include severe psychiatric illnesses, certain medical conditions like autoimmune diseases, knowledge of HD-tDCS that could bias results, or safety risks for brain stimulation or imaging.

Inclusion Criteria

My average pain level in the past week was 3 or more on a scale of 10.
I have been diagnosed with Fibromyalgia according to the 2011 criteria.
Healthy control participants must be capable of giving written informed consent
See 17 more

Exclusion Criteria

I do not use opioids or marijuana daily and have no history of substance abuse.
I will not take OTC pain meds on the day of my EEG/MRI.
I don't use opioids, marijuana daily, or have a history of substance abuse.
See 27 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Run-in Observation

Participants undergo a run-in observational period with EEG, QST, and MRI assessments

Up to 33 days
3 visits (in-person)

Treatment

Participants receive two weeks of HD-tDCS or Sham treatment with 5 daily sessions per week

2 weeks
10 visits (in-person)

Follow-up

Participants are monitored for changes in brain connectivity and EEG metrics after treatment

4 weeks
2 visits (in-person)

Treatment Details

Interventions

  • HD-tDCS treatments
  • Sham HD-tDCS treatments
Trial OverviewThe trial examines how a type of brain activity called explosive synchronization relates to chronic pain in fibromyalgia. It tests whether targeted non-invasive brain stimulation (HD-tDCS) can alter this activity and reduce pain. The study includes assessments using EEG and fMRI neuroimaging before and after sham or actual HD-tDCS treatment.
Participant Groups
5Treatment groups
Experimental Treatment
Placebo Group
Group I: Aim 3- HD-tDCS of ESExperimental Treatment4 Interventions
There will be two weeks of treatment in which participants will have 5 daily sessions of focused HD-tDCS or Sham per week.
Group II: Aim 3 - HD-tDCS of M1Experimental Treatment4 Interventions
There will be two weeks of treatment in which participants will have 5 daily sessions of focused HD-tDCS or Sham per week.
Group III: Aim 1 - Healthy controlExperimental Treatment2 Interventions
Participants will have three visits for this part along with a run-in observation period. An EEG with Quantitative Sensory Testing (QST) will be performed at visit 1 along with other measures. Additionally, the an MRI will be done at visit 2 along with other measures.
Group IV: Aim 1 - Fibromyalgia participantExperimental Treatment2 Interventions
Participants will have three visits for this part along with a run-in observation period. An EEG with Quantitative Sensory Testing (QST) will be performed at visit 1 along with other measures. Additionally, the an MRI will be done at visit 2 along with other measures.
Group V: Aim 3 - ShamPlacebo Group4 Interventions
There will be two weeks of treatment in which participants will have 5 daily sessions of focused HD-tDCS or Sham per week.

HD-tDCS treatments is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as HD-tDCS for:
  • Chronic pain
  • Fibromyalgia
  • Neuropathic pain
🇪🇺
Approved in European Union as HD-tDCS for:
  • Chronic pain
  • Fibromyalgia
  • Neuropathic pain
🇨🇦
Approved in Canada as HD-tDCS for:
  • Chronic pain
  • Fibromyalgia
  • Neuropathic pain

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Trials
886
Recruited
677,000+

Findings from Research

In a randomized clinical trial involving 35 women with fibromyalgia, ten sessions of active transcranial direct current stimulation (tDCS) significantly reduced pain levels immediately after treatment and maintained these improvements for up to 90 days.
The active tDCS group also experienced enhancements in quality of life and reductions in fatigue, indicating that this non-invasive treatment could be a beneficial option for managing fibromyalgia symptoms.
Effects of Anodal Transcranial Direct Current Stimulation on the Primary Motor Cortex in Women With Fibromyalgia: A Randomized, Triple-Blind Clinical Trial.Loreti, EH., Freire, AM., Alexandre da Silva, A., et al.[2023]
Transcranial direct current stimulation (tDCS) targeting the primary motor cortex significantly reduced pain in fibromyalgia patients compared to sham stimulation, with effects lasting for at least 3 weeks after treatment.
The treatment was generally safe, with only mild adverse events reported, and cognitive function remained stable across all treatment groups, suggesting that tDCS could be a promising noninvasive option for managing fibromyalgia symptoms.
A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia.Fregni, F., Gimenes, R., Valle, AC., et al.[2022]
In a randomized controlled trial with 23 fibromyalgia patients, daily sessions of anodal transcranial direct current stimulation (tDCS) combined with multidisciplinary rehabilitation led to a significant reduction in pain perception as measured by the SF-36 pain domain.
While patients tolerated the tDCS treatment well without adverse effects, the overall improvements in quality of life and other pain measures were not statistically significant, suggesting that while tDCS may help with pain, its effectiveness in broader treatment contexts remains uncertain.
Efficacy of transcranial direct current stimulation coupled with a multidisciplinary rehabilitation program for the treatment of fibromyalgia.Riberto, M., Marcon Alfieri, F., Monteiro de Benedetto Pacheco, K., et al.[2022]

References

Effects of Anodal Transcranial Direct Current Stimulation on the Primary Motor Cortex in Women With Fibromyalgia: A Randomized, Triple-Blind Clinical Trial. [2023]
A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. [2022]
3.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Efficacy of transcranial direct current stimulation coupled with a multidisciplinary rehabilitation program for the treatment of fibromyalgia. [2022]
Effiectiveness and safety of transcranial direct current stimulation in fibromyalgia: A systematic review and meta-analysis. [2022]
Efficacy of Home-Based Transcranial Direct Current Stimulation Over the Primary Motor Cortex and Dorsolateral Prefrontal Cortex in the Disability Due to Pain in Fibromyalgia: A Factorial Sham-Randomized Clinical Study. [2023]
Tolerability and blinding of high-definition transcranial direct current stimulation among older adults at intensities of up to 4 mA per electrode. [2023]
Effects of add-on transcranial direct current stimulation on pain in Korean patients with fibromyalgia. [2021]
Tolerability and blinding of 4x1 high-definition transcranial direct current stimulation (HD-tDCS) at two and three milliamps. [2020]
Using High-Definition Transcranial Alternating Current Stimulation to Treat Patients with Fibromyalgia: A Randomized Double-Blinded Controlled Study. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Focal modulation of the primary motor cortex in fibromyalgia using 4×1-ring high-definition transcranial direct current stimulation (HD-tDCS): immediate and delayed analgesic effects of cathodal and anodal stimulation. [2022]